{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:36:56Z","timestamp":1764981416518,"version":"3.46.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007613","name":"Ankara University","doi-asserted-by":"publisher","award":["TDK-2022-2763"],"award-info":[{"award-number":["TDK-2022-2763"]}],"id":[{"id":"10.13039\/100007613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.etap.2025.104861","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:09:20Z","timestamp":1761898160000},"page":"104861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of hsa-miR-29a-3p expression and diazepam biotransformation via CYP2C19 in alcohol withdrawal syndrome"],"prefix":"10.1016","volume":"120","author":[{"given":"Tu\u011fba","family":"Tezcan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selin","family":"\u00d6zkan-Kotilo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukaddes Asena","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Dan\u0131\u015fman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Ceren","family":"Bozmao\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenan Can","family":"Tok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130rem","family":"Kar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"G\u00fcm\u00fc\u015fta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130nci","family":"\u00d6zg\u00fcr-\u0130lhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halit Sinan","family":"S\u00fczen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek","family":"Kaya-Aky\u00fczl\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.etap.2025.104861_bib1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jksus.2017.03.002","article-title":"Diazepam induced oxidative DNA damage in cultured human lymphocytes","volume":"30","author":"Azab","year":"2018","journal-title":"J. King Saud. Univ. Sci."},{"issue":"6","key":"10.1016\/j.etap.2025.104861_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J. Consult. Clin. Psychol."},{"year":"1996","series-title":"Manual for the beck depression inventory second edition (BDI-II)","author":"Beck","key":"10.1016\/j.etap.2025.104861_bib3"},{"key":"10.1016\/j.etap.2025.104861_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1465814","article-title":"MicroRNA-665 and its potential role in drug response and survival outcomes in multiple myeloma: a preliminary study","volume":"16","author":"Bergantim","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.etap.2025.104861_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/cn5000056","article-title":"Classics in chemical neuroscience: diazepam (valium)","volume":"5","author":"Calcaterra","year":"2014","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.etap.2025.104861_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11739-018-1933-8","article-title":"Diagnosis and treatment of acute alcohol intoxication and alcohol withdrawal syndrome: position paper of the Italian Society on Alcohol","volume":"14","author":"Caputo","year":"2019","journal-title":"Intern. Emerg. Med."},{"issue":"3","key":"10.1016\/j.etap.2025.104861_bib7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.14336\/AD.2021.1023","article-title":"MiR-29a-3p improves acute lung injury by reducing alveolar epithelial cell PANoptosis","volume":"13","author":"Cui","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.etap.2025.104861_bib8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.omtn.2019.10.014","article-title":"MicroRNA-29a-3p reduces TNF\u03b1-induced endothelial dysfunction by targeting tumor necrosis factor receptor 1","volume":"18","author":"Deng","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"11","key":"10.1016\/j.etap.2025.104861_bib9","first-page":"38","article-title":"Treatment of alcohol withdrawal syndrome","volume":"39","author":"DeSimone","year":"2014","journal-title":"US Pharm."},{"issue":"10","key":"10.1016\/j.etap.2025.104861_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2298\/VSP0710659D","article-title":"Determination of diazepam and its metabolites in serum by the use of liquid chromatography-mass spectrometry method","volume":"64","author":"Dordevic","year":"2007","journal-title":"Vojnosanit. Pregl."},{"issue":"1","key":"10.1016\/j.etap.2025.104861_bib11","first-page":"70","article-title":"Reliability and validity of the Penn Alcohol Craving Scale (PACS) revised version for substance craving in male substance dependent inpatients","volume":"22","author":"Evren","year":"2011","journal-title":"Turk. J. Psychiatry"},{"key":"10.1016\/j.etap.2025.104861_bib12","first-page":"1","article-title":"The impact of genetic factors (CYP2D6) on drug metabolism","volume":"4","author":"Fejzullahu","year":"2018","journal-title":"Ayd\u0131N. J. Health"},{"year":"2009","series-title":"Guidelines for the treatment of alcohol problems","author":"Haber","key":"10.1016\/j.etap.2025.104861_bib13"},{"key":"10.1016\/j.etap.2025.104861_bib14","first-page":"3","article-title":"Beck depresyon envanterinin universite \u00f6grencileri icin ge\u00e7erliligi, g\u00fcvenilirli\u011fi","volume":"7","author":"Hisli","year":"1989","journal-title":"Psikol. Derg."},{"issue":"2","key":"10.1016\/j.etap.2025.104861_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13020285","article-title":"Clinical impact of the CYP2C19 gene on diazepam for the management of alcohol withdrawal syndrome","volume":"13","author":"Ho","year":"2023","journal-title":"J. Pers. Med."},{"issue":"10","key":"10.1016\/j.etap.2025.104861_bib16","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3390\/biom10101396","article-title":"The emerging role of MicroRNAs in regulating the drug response of cholangiocarcinoma","volume":"10","author":"Huang","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.etap.2025.104861_bib17","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some Pharmaceutical Drugs. Lyon (FR): International Agency for Research on Cancer; 1996. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 66.) Diazepam. Available from: \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK423855\/\u3009."},{"issue":"5","key":"10.1016\/j.etap.2025.104861_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12272-023-01448-z","article-title":"Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects","volume":"46","author":"Kang","year":"2023","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/j.etap.2025.104861_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3904\/kjim.2009.24.1.1","article-title":"Overview of therapeutic drug monitoring","volume":"24","author":"Kang","year":"2009","journal-title":"Korean J. Intern. Med."},{"issue":"3","key":"10.1016\/j.etap.2025.104861_bib20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI200523625","article-title":"Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice","volume":"115","author":"Kralic","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.etap.2025.104861_bib21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbrc.2014.02.024","article-title":"microRNA-34a is associated with expression of key hepatic transcription factors and cytochromes P450","volume":"445","author":"Lamba","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.etap.2025.104861_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13111096","article-title":"MiRNAs and miRNA polymorphisms modify drug response","volume":"13","author":"Li","year":"2016","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.etap.2025.104861_bib23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s12020-018-1753-7","article-title":"Exosomal microRNA-29a mediates cardiac dysfunction and mitochondrial inactivity in obesity-related cardiomyopathy","volume":"63","author":"Li","year":"2019","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.etap.2025.104861_bib24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2125.2009.03578.x","article-title":"Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17","volume":"69","author":"Li-Wan-Po","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.etap.2025.104861_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/ijp.ijp_706_22","article-title":"Prevalence of CYP2C9 and CYP2C19 variants and the impact on clopidogrel efficacy in patients having CYPC19*2 variant","volume":"55","author":"Mehta Meha","year":"2023","journal-title":"Indian J. Pharmacol."},{"issue":"1","key":"10.1016\/j.etap.2025.104861_bib26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1186\/s12913-019-4421-6","article-title":"Unlawful dispensing practice of diazepam: a simulated client approach in community pharmacies in the north-west of Dar-es-Salaam region, Tanzania","volume":"19","author":"Mikomangwa","year":"2019","journal-title":"BMC Health Serv. Res."},{"issue":"1","key":"10.1016\/j.etap.2025.104861_bib27","first-page":"21","article-title":"Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome","volume":"100","author":"Nuss","year":"2004","journal-title":"West Va. Med. J."},{"issue":"3","key":"10.1016\/j.etap.2025.104861_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3956(01)00017-6","article-title":"Differential analysis of behavior and diazepam-induced alterations in C57BL\/6N and BALB\/c mice using the modified hole board test","volume":"35","author":"Ohl","year":"2001","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.etap.2025.104861_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/kjm2.12670","article-title":"miR-29a-3p promotes the regulatory role of eicosapentaenoic acid in the NLRP3 inflammasome and autophagy in microglial cells","volume":"39","author":"Pan","year":"2023","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"3","key":"10.1016\/j.etap.2025.104861_bib30","first-page":"234","article-title":"Physiologically based pharmacokinetic (PBPK) modeling of gliclazide for different genotypes of CYP2C9 and CYP2C19","volume":"48","author":"Park","year":"2025","journal-title":"Arch. Pharmacal Res."},{"issue":"1","key":"10.1016\/j.etap.2025.104861_bib31","first-page":"17","article-title":"Epigenetic therapy-a new development in pharmacology","volume":"123","author":"Peedicayil","year":"2006","journal-title":"Indian J. Med. Res."},{"issue":"5","key":"10.1016\/j.etap.2025.104861_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40263-014-0163-5","article-title":"Inpatient management of acute alcohol withdrawal syndrome","volume":"28","author":"Perry","year":"2014","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.etap.2025.104861_bib33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11064-019-02944-9","article-title":"Neurochemical evidence of preclinical and clinical reports on target-based therapy in alcohol used disorder","volume":"45","author":"Prajapati","year":"2020","journal-title":"Neurochem. Res."},{"issue":"15","key":"10.1016\/j.etap.2025.104861_bib34","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCULATIONAHA.109.914820","article-title":"Pharmacogenomics: the genetics of variable drug responses","volume":"123","author":"Roden","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.etap.2025.104861_bib35","doi-asserted-by":"crossref","DOI":"10.7860\/JCDR\/2015\/13407.6538","article-title":"Alcohol withdrawal syndrome: Benzodiazepines and beyond","author":"Sachdeva","year":"2015","journal-title":"J. Clin. Diagn. Res. Dr. 9(9) VE01VE07."},{"issue":"6","key":"10.1016\/j.etap.2025.104861_bib36","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/gim.2017.156","article-title":"Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics","volume":"20","author":"Santos","year":"2018","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.etap.2025.104861_bib37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/1060028016629161","article-title":"Treatment of severe alcohol withdrawal","volume":"50","author":"Schmidt","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.etap.2025.104861_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117364","article-title":"Coding SNPs in hsa-miR-1343-3p and hsa-miR-6783-3p target sites of CYP2C19 modulates clopidogrel response in individuals with cardiovascular diseases","volume":"245","author":"Sharma","year":"2020","journal-title":"Life Sci."},{"issue":"33","key":"10.1016\/j.etap.2025.104861_bib39","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.3748\/wjg.14.5197","article-title":"Maintenance time of sedative effects after an intravenous infusion of diazepam: a guide for endoscopy using diazepam","volume":"14","author":"Sugimoto","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.etap.2025.104861_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116805","article-title":"Development of a sample preparation and analysis method for therapeutic monitoring of diazepam and major metabolite in alcohol withdrawal syndrome treatment","volume":"260","author":"Tok","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"18","key":"10.1016\/j.etap.2025.104861_bib41","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1158\/0008-5472.CAN-06-1403","article-title":"MicroRNA regulates the expression of human cytochrome P450 1B1","volume":"66","author":"Tsuchiya","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.etap.2025.104861_bib42","first-page":"163","article-title":"Turkish version of the beck anxiety inventory: psychometric properties","volume":"12","author":"Ulusoy","year":"1998","journal-title":"J. Cogn. Psychother."},{"key":"10.1016\/j.etap.2025.104861_bib43","article-title":"CYP2D6 copy number determination using digital PCR","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.etap.2025.104861_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176955","article-title":"MicroRNA 29a alleviates mitochondrial stress in diet-induced NAFLD by inhibiting the MAVS pathway","volume":"982","author":"Yang","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.etap.2025.104861_bib45","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.3390\/ijms21186884","article-title":"miR-29a Modulates GSK3\u03b2\/SIRT1-linked mitochondrial proteostatic stress to ameliorate mouse non-alcoholic steatohepatitis","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.etap.2025.104861_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bcp.2015.08.094","article-title":"MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells","volume":"98","author":"Yu","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.etap.2025.104861_bib47","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s13258-022-01347-5","article-title":"Correlation analysis and prognostic value of miR-29a-3p expression and CYP2C19 genotypes in exfoliated cells from tongue coating of patients with gastroesophageal reflux disease","volume":"45","author":"Zhang","year":"2023","journal-title":"Genes Genom."},{"issue":"1","key":"10.1016\/j.etap.2025.104861_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2125.2007.02846.x","article-title":"Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects","volume":"64","author":"Zhang","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.etap.2025.104861_bib49","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/mol.112.078386","article-title":"Human CYP2C8 is post-transcriptionally regulated by microRNAs 103 and 107 in human liver","volume":"82","author":"Zhang","year":"2012","journal-title":"Mol. Pharmacol."}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668925002364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668925002364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:34:16Z","timestamp":1764981256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668925002364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":49,"alternative-id":["S1382668925002364"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2025.104861","relation":{},"ISSN":["1382-6689"],"issn-type":[{"type":"print","value":"1382-6689"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of hsa-miR-29a-3p expression and diazepam biotransformation via CYP2C19 in alcohol withdrawal syndrome","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2025.104861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104861"}}